Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Antioxidants (Basel, Switzerland)|August 29, 2024
Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory StudyMarco Fiore, Chiara Cambieri, Laura Libonati, et al.Journal of Neurology|June 26, 2025
Mitochondrial pathology in inflammatory myopathies: a marker of worse clinical outcomeAntonio Lauletta, Luca Bosco, Gioia Merlonghi, et al.Inflammation and Regeneration|March 9, 2023
Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse modelsCassandra Margotta, Paola Fabbrizio, Marco Ceccanti, et al.Autoimmunity Reviews|February 17, 2020
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patientsMatteo Garibaldi, Laura Fionda, Fiammetta Vanoli, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 23, 2016
Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug DeliveryUdi Vazana, Ronel Veksler, Gaby S Pell, et al.Journal of Medical Genetics|September 12, 2019
Myoclonic epilepsy, parkinsonism, schizophrenia and left-handedness as common neuropsychiatric features in 22q11.2 deletion syndromeMartina Fanella, Marianna Frascarelli, Caterina Lambiase, et al.Journal of the Peripheral Nervous System : JPNS|August 3, 2023
Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)Luca Leonardi, Rocco Costanzo, Francesca Forcina, et al.European Journal of Neurology|June 4, 2025
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic CarriersGuido Primiano, Marco Luigetti, Delia Righi, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 16, 2026
Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort studyDomenico Plantone, Delia Righi, Angela Romano, et al.Current Gene Therapy|February 24, 2026
Padlock Assay in Transthyretin Amyloidosis: A Feasibility StudyMaria Grazia Di Certo, Francesca Gabanella, Claudio Passananti, et al.Pageof 7